Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.64 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.64 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.64 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.64 |
| ▸ | HTR2A | P28223 | 1/20 | 0.64 |
| ▸ | HTR2C | P28335 | 1/20 | 0.64 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.64 |
| ▸ | HRH1 | P35367 | 1/20 | 0.64 |
| ▸ | DRD3 | P35462 | 1/20 | 0.64 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.64 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.64 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.61 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.58 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.58 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.56 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.56 |
| ▸ | PPARG | P37231 | 7/20 | 0.56 |
| ▸ | PPARD | Q03181 | 7/20 | 0.56 |
| ▸ | PPARA | Q07869 | 7/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3146559 | 1.00 | TDP1 (0.64) | TDP1CHRM1AKR1A1CHRM3HTR2A | |
| SCHEMBL11508833 | 1.00 | TDP1 (0.64) | TDP1CHRM1AKR1A1CHRM3HTR2A | |
| SCHEMBL3447478 | 1.00 | TDP1 (0.64) | TDP1CHRM1AKR1A1CHRM3HTR2A | |
| SCHEMBL11200978 | 1.00 | TDP1 (0.64) | TDP1CHRM1AKR1A1CHRM3HTR2A | |
| SCHEMBL3446766 | 1.00 | TDP1 (0.64) | TDP1CHRM1AKR1A1CHRM3HTR2A | |
| Ammonia Solution, Strong SCHEMBL28711791 | 0.98 | TDP1 (0.61) | TDP1CHRM1AKR1A1CHRM3HTR2A | |
| SCHEMBL3141989 | 0.98 | TDP1 (0.67) | TDP1CHRM1AKR1A1CHRM3HTR2A | |
| Arundic Acid SCHEMBL6943192 | 0.96 | FFAR4 (0.65) | TDP1CHRM1AKR1A1CHRM3HTR2A | |
| Hexanoate SCHEMBL27984947 | 0.94 | TDP1 (0.61) | TDP1CHRM1AKR1A1CHRM3HTR2A | |
| Myristic Acid SCHEMBL25309729 | 0.92 | FFAR4 (0.69) | TDP1ALDH1A1FFAR4FFAR1FOLH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7579375-B2 | Branched carboxylic acid compound and use thereof | ONO PHARMACEUTICAL CO., LTD. (JP) | 2009-08-25 | — | — | US | disclosed |
| US-7579375-B2 | Branched carboxylic acid compound and use thereof | ONO PHARMACEUTICAL CO., LTD. (JP) | 2009-08-25 | — | — | US | disclosed |
| US-7579375-B2 | Branched carboxylic acid compound and use thereof | ONO PHARMACEUTICAL CO., LTD. (JP) | 2009-08-25 | — | — | US | disclosed |
| US-20070167522-A1 | Branched carboxylic acid compound and use thereof | ONO PHARMACEUTICAL CO LTD | 2007-07-19 | — | — | US | disclosed |
| US-20070167522-A1 | Branched carboxylic acid compound and use thereof | ONO PHARMACEUTICAL CO LTD | 2007-07-19 | — | — | US | disclosed |
| US-20070167522-A1 | Branched carboxylic acid compound and use thereof | ONO PHARMACEUTICAL CO LTD | 2007-07-19 | — | — | US | disclosed |
| EP-1650182-A1 | BRANCHED CARBOXYLIC ACID COMPOUND AND USE THEREOF | ONO PHARMACEUTICAL CO., LTD. (JP) | 2006-04-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070167522-A1 | Branched carboxylic acid compound and use thereof | BDNF, CA1, BACE1 | TDP1 2794/4885CHRM1 129/4885AKR1A1 16/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.